What ovarian reserve testing measures, and what it does not
Ovarian reserve is a laboratory and imaging concept. It describes the pool of remaining oocytes, not the chance of a live birth in any individual cycle. Three measures are commonly discussed, and they answer slightly different questions.
Anti-Müllerian hormone (AMH) is produced by small follicles in the ovaries and is measured in blood. Because it can be checked on most days of the menstrual cycle, it is often used as a first-line marker of ovarian response. Antral follicle count (AFC) is a transvaginal ultrasound count of small resting follicles, usually performed in the early part of the cycle. Follicle-stimulating hormone (FSH), often with estradiol, is measured early in the cycle; a raised FSH can suggest reduced reserve, but it is less informative than AMH or AFC for predicting response to stimulation.
None of these tests measures egg quality. A normal AMH does not rule out difficulty conceiving, and a low AMH does not by itself mean pregnancy is impossible. Age remains the strongest single factor in fertility counselling. This is why a specialist interprets results alongside your age, menstrual pattern, medical and surgical history, and any previous fertility treatment.
A further limit matters for planning: reserve tests are used mainly to anticipate how ovaries may respond to stimulation and to inform counselling. They are not a screening test for infertility in someone who has not tried to conceive, and they do not replace an assessment of the fallopian tubes, uterus, sperm or ovulation. Ask the clinician which of those questions your test set is meant to answer.
Why the same result can lead to different advice
Two patients with the same AMH can receive different recommendations because the test result is only one input. A specialist considers whether you are trying to conceive now, how long you have been trying, your age, whether you have regular ovulation, any history of ovarian surgery, chemotherapy or genetic conditions, and whether you are considering egg freezing, IVF or no treatment at all.
For someone considering fertility preservation, reserve testing may inform urgency but cannot guarantee how many eggs a cycle will yield or how many would be suitable for storage. For someone already planning IVF, the result may influence the starting dose of stimulation medication, but the treating clinician decides that and adjusts it during monitoring. For someone with no immediate fertility plans, a low result can cause anxiety without changing what is medically useful to do next.
This is the practical reason to ask what decision the test is meant to support. If the answer is unclear, that is a fair question for the consultation. A result without a plan can create worry without benefit, and a plan without a result can be premature.
Chinese reproductive medicine services are hospital-based, and the clinician who orders the tests is responsible for interpreting them. A coordinator can help you prepare records and arrange an appointment, but cannot interpret results or advise on treatment.
What to bring to an ovarian reserve consultation in China
Records do more work than a long email. The receiving clinician needs to see the actual results, not a summary, because units and reference ranges differ between laboratories. Bring or share the original reports for any AMH, FSH, estradiol, thyroid and prolactin tests, plus any pelvic ultrasound reports, including the day of the cycle on which each was performed.
A short fertility history is also useful: your age, cycle length and regularity, date of last menstrual period, any pregnancies, any surgery on the ovaries or fallopian tubes, any diagnosis such as endometriosis or polycystic ovary syndrome, and any current medication. If you have had fertility treatment before, include the stimulation protocol, doses, number of eggs retrieved and outcome, because previous response is directly relevant to planning.
Ask the hospital in advance whether it wants tests repeated in its own laboratory or accepts recent external results. Do not assume either way. Some clinicians prefer a current AMH from a laboratory they know; others will review recent reports and only repeat what is needed. The answer depends on the hospital and the clinician, so confirm it before travelling.
If you are sharing records before an appointment, a brief summary with the main question is enough for a first enquiry. Detailed reports can follow once the clinical team has indicated what it needs.
Timing, cycle day and practical preparation
AMH can generally be measured without regard to cycle day, while FSH and estradiol are usually checked in the early follicular phase, and AFC is usually performed early in the cycle. If you are travelling from abroad, that timing affects how you plan appointments. Ask the hospital which tests it intends to order and on which days they should be done, then work backwards to your travel dates.
Do not schedule a trip on the assumption that every test must be done in one visit. Some results may be available quickly, others may need a repeat, and the clinician may want to see you again after results. Confirm the hospital's actual process rather than relying on a general expectation.
Bring your passport and any hospital registration documents the appointment requires. If you need interpretation, arrange it in advance and confirm whether the hospital provides it or whether you need a separate interpreter. Ask about payment arrangements for consultations and tests directly with the hospital; coordination fees with ChinaSpecialistCare are separate from hospital charges.
If you have symptoms such as pelvic pain, very irregular bleeding or a suspected ovarian mass, those need clinical assessment rather than a reserve test alone. Tell the clinician about them at the first contact.
Questions that make the consultation more useful
A consultation is more productive when you arrive with specific questions. These are worth asking the treating specialist, and the answers should be recorded in your own notes.
Ask which tests are being ordered and what each one is meant to show. Ask how the result will change the recommendation, if at all. Ask whether a repeat test would add information or simply repeat the same measurement. Ask what the clinician would advise if the result were low, normal or high, so you understand the range of possibilities before you see the number.
For fertility preservation, ask what the realistic options are, what the process involves and what the clinician cannot promise. For IVF planning, ask how the result might influence protocol choice and monitoring. For anyone not currently trying to conceive, ask whether testing now is useful or whether it can wait.
It is reasonable to ask about the clinician's experience with your specific situation, and to ask for the plan in writing. It is not reasonable to expect a guarantee of pregnancy, a fixed number of eggs or a prediction of outcome. A specialist who offers certainty about those things is not giving you a reliable picture.
Limits, safety and the next step
Ovarian reserve testing is generally low-risk: blood tests and a transvaginal ultrasound carry minimal physical risk, though the ultrasound may be uncomfortable and is usually avoided in certain situations such as virginity or specific anatomical concerns unless discussed. The greater risk is misinterpretation, particularly treating a low AMH as a definitive diagnosis or a high AMH as a guarantee.
Results should be interpreted by a clinician who can see the whole picture, and decisions about stimulation medication, egg freezing or IVF belong to that clinician and to you. A remote records review can help you understand what a report says and prepare questions, but it does not replace an in-person assessment where one is needed, and it does not establish eligibility for any treatment.
If you are considering care in China, the practical next step is a short initial enquiry describing your age, your main question and whether you already have recent results. ChinaSpecialistCare can help identify missing information and suggest a relevant next step; the hospital and its clinicians decide on tests, suitability and treatment. An initial enquiry is free and does not require buying a proxy consultation.
Sources & scope of this guide
References and official service information relevant to this guide.
This is general planning information and has not been individually reviewed by a doctor. Medical decisions and personal treatment advice come from your treating clinicians.
